Prima Medical Center Saigon, Glaucoma
Good news for glaucoma patients: First treatment in 25 years showing promise
18 November, 2023
Roclanda, by Santen, is the first new treatment for glaucoma in the UK for 25 years.
A new glaucoma treatment has recently been launched by Santen, and so far it is showing promising results. Roclanda, is the first new treatment for glaucoma in the UK for 25 years. An exciting development in glaucoma care, this new treatment option could help save the sight of many thousands living with this serious eye condition.
Roclanda – How it works
Roclanda is an eye drop that contains the combination of a Rho kinase inhibitor (Netarsudil) and the commonly used glaucoma drug, latanoprost. It works by increasing the outflow of aqueous fluid from the eyes in the conventional way (through the trabecular meshwork).
Usually, medications for glaucoma increase outflow through other areas of the eye (unconventional), or reduce the amount of fluid the eye produces. By opening up this conventional fluid outflow pathway, this treatment compliments the other commonly used treatments in glaucoma and therefore may have some particular benefits.
Glaucoma Screening at Prima Medical Center Saigon
Roclanda – Key benefits
For patients already taking a number of other glaucoma medications, there is evidence that shows Roclanda can still have a strong effect.
The key benefits of the new treatment are:
- Convenience – only once daily dosage required
- Effective even when used in combination with other glaucoma treatments
- Lowers pressure even when the starting pressure is low
Roclanda – Side effects
The risks associated with Roclanda are generally mild to moderate, which is why it is authorised for use in the EU. The main side-effect is conjunctival hyperaemia (red eye). However, this is not a serious side-effect, or vision threatening and can be easily resolved by ceasing the treatment.
Of course, for some patients, medications alone will not resolve their condition and they will require glaucoma surgery. If you need a glaucoma consultation or treatment, please feel free to visit Prima Medical Center Saigon, a member of the elite World Association of Eye Hospitals.
Our Ophthalmology Care Team
- Dr THAO Vo, Chief Medical Officer , Prima Medical Center Saigon
- Dr AN Trinh, Head of General Ophthalmology
- Dr BINH Tran, Senior Consultant
- Dr TRAN Nguyen, Consultant
If you need an glaucoma assessment, please have a visit to Prima Medical Center Saigon
- Address: 27 Ky Dong St, District 3, HCMC
- Website: https://primahealth.vn/en/
- Business Hours: 07:30 – 17:00 from Monday – Saturday
- HOTLINE: 0919-209-039 or 1900 – 9115
Prima Saigon recommends that clients should reserve their intended consultation at least three days before their visit for convenience and less waiting time.
Roclanda, by Santen, is the first new treatment for glaucoma in the UK for 25 years.
A new glaucoma treatment has recently been launched by Santen, and so far it is showing promising results. Roclanda, is the first new treatment for glaucoma in the UK for 25 years. An exciting development in glaucoma care, this new treatment option could help save the sight of many thousands living with this serious eye condition.
Roclanda – How it works
Roclanda is an eye drop that contains the combination of a Rho kinase inhibitor (Netarsudil) and the commonly used glaucoma drug, latanoprost. It works by increasing the outflow of aqueous fluid from the eyes in the conventional way (through the trabecular meshwork).
Usually, medications for glaucoma increase outflow through other areas of the eye (unconventional), or reduce the amount of fluid the eye produces. By opening up this conventional fluid outflow pathway, this treatment compliments the other commonly used treatments in glaucoma and therefore may have some particular benefits.
Glaucoma Screening at Prima Medical Center Saigon
Roclanda – Key benefits
For patients already taking a number of other glaucoma medications, there is evidence that shows Roclanda can still have a strong effect.
The key benefits of the new treatment are:
- Convenience – only once daily dosage required
- Effective even when used in combination with other glaucoma treatments
- Lowers pressure even when the starting pressure is low
Roclanda – Side effects
The risks associated with Roclanda are generally mild to moderate, which is why it is authorised for use in the EU. The main side-effect is conjunctival hyperaemia (red eye). However, this is not a serious side-effect, or vision threatening and can be easily resolved by ceasing the treatment.
Of course, for some patients, medications alone will not resolve their condition and they will require glaucoma surgery. If you need a glaucoma consultation or treatment, please feel free to visit Prima Medical Center Saigon, a member of the elite World Association of Eye Hospitals.
Our Ophthalmology Care Team
- Dr THAO Vo, Chief Medical Officer , Prima Medical Center Saigon
- Dr AN Trinh, Head of General Ophthalmology
- Dr BINH Tran, Senior Consultant
- Dr TRAN Nguyen, Consultant
If you need an glaucoma assessment, please have a visit to Prima Medical Center Saigon
- Address: 27 Ky Dong St, District 3, HCMC
- Website: https://primahealth.vn/en/
- Business Hours: 07:30 – 17:00 from Monday – Saturday
- HOTLINE: 0919-209-039 or 1900 – 9115
Prima Saigon recommends that clients should reserve their intended consultation at least three days before their visit for convenience and less waiting time.
